Speakers

Confirmed Plenary Lecturers to date

-Prof. Dr. Donald Hilvert, Laboratory of Organic Chemistry, ETH Zürich, Switzerland: Tailoring the Properties of Properties of Proteins through Laboratory Evolution

-Prof. Jonathan Knowles, President Group Research, F. Hoffmann-La Roche Ltd, Switzerland

-Dr. Dwight S. Seferos, International Institute for Nanotechnology, Northwestern University, USA: Nanomedicine

-Prof. Svante Paabo, Director, Department of Genetics, Max-Planck-Institute of Evolutionary Anthropology, Germany: The Neanderthal Genome Project

-Janez Potocnik, Commissioner for Science & Research, European Commission, Belgium

-Dr. Ismail Serageldin, Director, Bibliotheca Alexandrina; Chairman, BioVisionAlexandria, Egypt: Biotechnology & Society

-Sir. Greg Winter, Acting Director, MRC Laboratory of Molecular Biology, UK: Antibody Engineering & Therapeutic Antibodies

Confirmed Speakers & Chairmen to date

-Dr. Tom Adams, Director of Yield and Emerging Technologies, Monsanto, USA

-Dr. Alfredo Aguilar, Head of Unit Biotechnology, Directorate Food, Agriculture and Biotechnology, Research Directorate General, European Commission

-Dr. Mohamed Ait-Kadi, President of the General Council of Agricultural Development- Ministry of Agriculture, Rural Development, and Forestry, Morocco

-Prof. Lilia Alberghina, Professor, Dept. of Biotechnology and Biosciences, University of Milano-Bicocca, Italy

-Prof. Klaus Ammann, Chairman EFB Section on Biodiversity, Member Steering Committee PRRI, University of Bern, Switzerland

-Prof. Leif Andersson, Professor in Functional Genomics, Uppsala University, Sweden

-Dr. Siv Andersson, Head of the Department of Evolution, Genomics and Systematics at the Evolutionary Biology Center at Uppsala University, Sweden

-Dr Wilhelm Ansorge, ETH Lausanne, Switzerland

-Dr. François Arcand, CEO, ERA Biotech, Barcelona, Spain

-Dr. Paulo Arruda, Professor of Genetics, Universidade Estadual de Campinas and Scientific Director, Alelllyx Applied Genomics, Brazil

-Dr. Frank Baganz, Department of Biochemical Engineering, University College London, UK

-Dr. Gerard Barry, Rice Crop Team Leader, International Rice Research Institute (IRRI), Philippines

-Dr. Marin Berovic, Chairman EFB Section on Biochemical Engineering Science; University of Ljubljana, Slovenia

-Dr. Jaume Bertranpetit, Professor, Dept. of Experimental & Health Sciences, Pompeu Fabra University, Spain

-Prof. Carl Borrebaeck, Professor & Chair, Department of Immunotechnology, Lund University, Sweden

-Dr. Thomas Bruhn, Science Officer, European Medical Research Councils (EMRC), European Science Foundation (ESF), France

-Prof. Dr. Jochen Büchs, Head of Chair of Biochemical Engineering, RWTH Aachen University, Germany

-Dr. Dirk Burdinski, Bio-Molecular Engineering, Philips Research Laboratories, The Netherlands

-Prof. Manuel Canovas, Professor, Biochemical Engineering, University of Murcia, Spain

-Dr. David Caparrós-Ruiz, Consorci CSIC-IRTA, Spain

-Dr. Johan Cardoen, CEO, CropDesign N.V., Belgium

-Dr. Alberico Catapano, University of Milano, Italy

-Prof. Zhangliang Chen, President, China Agricultural University, China

-Dr. Torkil Jønch Clausen, DHI Water and Environment, Denmark

-Dr. Philippe Cupers, Scientific officer, Unit Major Diseases - Directorate Health Research, DG Research, European Commission

-Dr. Leo de Graaff, Wageningen University and Research Centre, The Netherlands

-Dr. Ad de Laat, Director Cosun Food technology Centre, Royal Cosun, The Netherlands

-Dr. Robert DiCosimo, Senior Research Fellow, DuPont Central Research and Development, USA

-Dr. Stefan Diez, Research Group Leader, Max-Planck-Institute of Molecular Cell Biology and Genetics, Germany

-Ms. Duygu Dikicioglu, Bogazici University, Turkey

-Dr. Jorgen Dirach, Dr. Jorgen Dirach, Chairman EFB Section on Medicines Development; Director, Novo Nordisk, Denmark

-Prof. Mike Eaton, Head of Biological Chemistry, UCB group, UK

-Dr. Jürgen Eck, Member of the Managing Board and Head of Research & Development (CTO), B.R.A.I.N AG, Germany

-Dr. Michael Egholm, Vice-President of R&D, 454 Life Sciences Inc., USA

-Prof. Turkan Eldem, Vice-Chair EFB section on Medicines Development, Head of Pharmaceutical Biotechnology Department, Hacettepe University, Turkey

-Prof. Paul Engel, Professor of Biochemistry, Conway Institute, University College Dublin, Ireland

-Prof. Juan Ferre, Professor in Genetics, University of Valencia, Spain

-Dr. Pau Ferrer, Research Associate, Universitat Autònoma de Barcelona, Spain

-Dr. Hans Peter Fischer, Chief Scientific Officer, Genedata AG, Switzerland

-Prof. Dr. Rainer Fischer, Senior Executive Director, Fraunhofer IME, Germany

-Dr. David Fischhoff, Vice-President, Technology Strategy & Development, Monsanto, USA

-Prof. Dr. Ruth Freitag, Chair for Process Biotechnology, University of Bayreuth, Germany

-Prof. Maria Garcia-Parajo, Group Leader BioNanophotonics, IBEC- Catalonian Institute for Bioengineering, Barcelona Scientific Park, Spain

-Prof. Dr. J.G.E. Gardeniers, Professor in Mesoscale Chemical Systems, MESA+ Institute for Nanotechnology, The Netherlands

-Dr. Larry Gold, CEO & Chairman of the Board, SomaLogic Inc., USA

-Prof. Wilhelm Gruissem, Professor of Plant Biotechnology, ETH Zurich, Switzerland

-Dr. Juergen Hass, Associate Director Upstream Projects Coordination, Boehringer Ingelheim Pharma GmbH & Co. KG, Germany

-Dr. Pierre Hilson, Principal Investigator, Functional Genomics Group, Ghent University, Belgium

-Dr. Francois Hirsch, Governance & Ethics, Directorate General for Research (DG RTD), European Commission

-Prof. Sophia Hober, Professor, Dept. of Proteomics, Royal Institute of Technology, (KTH), Sweden

-Dr. Timothy Hobley, Associate Professor, Technical University Denmark

-Dr. Jörg Hoheisel, Head of Division of Functional Genome Analysis, German Cancer Research Centre (DKFZ), Germany

-Prof. Stefan Hohmann,Professor, Dept. of Cell & Molecular Biology/Microbiology, Göteborg University, Sweden

-Prof. So Iwata, Director of the Centre for Structure Biology, Division of Molecular Biosciences, Imperial College London, UK

-Dr. Clive James, Chairman and Founder of ISAAA (International Service for the Acquisition of Agri-biotech Applications), Canada

-Dr. Raymond Jacquet, Head of cell culture, Selexis SA, Switzerland

-Dr. Alois Jungbauer, Dept. Biotechnology, University of Natural Resources & Applied Life Sciences, Austria

-Dr. Fotis Kafatos, President of the European Research Council; Chair of Immunogenomics at Imperial College London, UK

-Prof. Olli Kallioniemi, Professor VTT Technical Research Centre of Finland & University of Turku

-Dr. Anil Kapur, Managing Director of the World Diabetes Foundation, Denmark

-Prof. Douglas Kell, Professor of Chemistry & Director, Manchester Centre for Integrative Systems Biology, University of Manchester, UK

-Dr. Alastair Kent, Director of Genetic Interest Group; President of European Genetic alliances Network, UK

-Prof. James Kirkpatrick, President of European Society for Biomaterials; Professor & Director, Institute of Pathology, Johannes Gutenberg University, Germany

-Daniel Klein-Marcuschamer, PhD Candidate in Chemical Engineering, Massachusetts Institute of Technology, USA

-Dr. Julian Kinderlerer, Member Steering Committee PRRI, South Africa

-Prof. Akihiko Kondo, Kobe University, Japan

-Dr. Kostas Kostarelos, Professor & Deputy Head, Centre for Drug Delivery Research, School of Pharmacy, University of London, UK

-Dr. Alan L. Kriz, Global Product Manager, BASF Plant Science LLC, USA

-Dr. Bernhard Kuster, Vice-President, Analytical Sciences & Informatics, Cellzome AG, Germany

-Prof. Ulf Landegren, Professor, Dept. of Genetics and Pathology, Rudbeck Laboratory, Sweden

-Prof. Peter Leadlay, Department of Biochemistry, University of Cambridge, UK

-Prof. Dr. Andreas Liese, Head of Institute of Technical Biocatalysis, Hamburg University of Technology (TUHH), Germany

-Dr. Pekka Lindroos, Chief Counsellor, Biotechnology Policy, Ministry of Trade and Industry, Finland

-Prof. Jennifer Littlechild, Professor of Biological Chemistry and Director of the Henry Wellcome Centre for Biocatalysis at University of Exeter, UK

-Dr. Vito Lorusso, Imaging Technology Head at Bracco Research Centre, Bracco Imaging S.p.A., Italy

-Prof. Dr. Andreas Lübbert, Head of Centre of Bioprocess Engineering, Martin-Luther-Universität, Germany

-Prof. Dr. Ing. Reiner Luttmann, Head of Research Center of Bioprocess Engineering and Analytical Techniques, Hamburg University of Applied Sciences, Germany

-Prof. Gary Lye, Professor of Biochemical Engineering, University College London, UK

-Dr. Stephen Mahler, Associate Professor, Australian Institute for Bioenginerring and Nanotechnology, University of Queensland, Australia

-Dr. Outi Maki-Ikola, Senior Scientific Administrator, Pre-Authorisation Human Unit/ Safety and Efficacy Sector, European Medicines Agency (EMEA)

-Prof. Carl-Fredrik Mandenius, Professor, Linkoping University, Sweden

-Prof. Seiichi P.T. Matsuda, Department of Chemistry, Rice University, USA

-Dr. Diethard Mattanovich, Professor, University of Natural Resources and Applied Life Sciences, Austria

-Dr. Yariv Mazor, Postdoctoral Fellow, Department of Chemical Engineering, University of Texas, USA

-Prof. David McConnell, Chairman EFB Task Group European Action on Global Life Sciences (EAGLES), Smurfit Institute of Genetics, Ireland

-Dr. Thomas Metcalfe, Head of Biomarker Program, F. Hoffmann-La Roche Ltd, Switzerland

-Dr. Kim Meulenbroeks, Deputy Executive Secretary PRRI, The Netherlands

-Prof. Anton Middelberg, Professor, The University of Queensland, Australia

-Dr. Paul Millner, Reader in Biotechnology, University of Leeds, UK

-Prof. Dr. David Mitchell, Adjunct Professor, Federal University of Parana

-Dr. Maurice Moloney, Chief Scientific Officer, SemBioSys Genetics Inc, Canada

-Prof. Lars Montelius, Department of Physics & The Nanometer Structure Consortium, Lund University, Sweden

-Prof. Tom Murray, President & CEO, The Hastings Center, USA

-Prof. Dr. Dario Neri, Professor, Swiss Federal Institute of Technology Zurich, Switzerland

-Prof. Peter Neubauer, Professor for Bioprocess Engineering, University of Oulu, Finland

-Dr. Twalib Ngoma, Executive Director, Ocean Road Cancer Institute (ORCI), Tanzania

-Prof. Alvin Nienow, Emeritus Professor of Biochemical Engineering, The University of Birmingham, UK

-Dr. Henk Noorman, Principal Scientist Fermentation, DSM Anti-Infectives, The Netherlands

-Dr. Per-Åke Nygren, Professor, Dept of Biotechnology, Royal Institute of Technology (KTH), Sweden

-Dr. Andreani Odysseos, Director of Biomedical Research,EPOS-Iasis, R&D; Special Scientist, University of Cyprus

-Dr. Kirsi-Marja Oksman-Caldentey, Head of Plant Biotechnology, VTT Technical Research Centre of Finland

-Dr. Mr. Jose Otero, Center for Microbial Biotechnology, BioCentrum-Technical University of Denmark

-Dr. Laura Palomares, Principal Scientist, Biotechnology Institute, Autonomous University of Mexico

-Dr. Sven Panke, Bioprocess Laboratory, ETH Zurich, Switzerland

-Dr. Ramesh Patel, Director, Enzyme Technology, Process Research & Development, Bristol-Myers Squibb, USA

-Dr. Marnix Peferoen, CropDesign N.V., Belgium

-Dr. Johan Peleman, Director R&D, Nunhems BV, The Netherlands

-Dr. Staffan Persson, Group Leader, Max Planck Institute of Molecular Plant Physiology, Germany

-Mrs. Spela Peternel, Research Assistant, National Institute of Chemistry, Slovenia

-Dr. Andrea Pfeifer, Postdoctoral Fellow, Systems Biology of Signal Transduction, German Cancer Research Center (DKFZ), Germany

-Prof. Luis Joaquim Pina da Fonseca, Centro de Engenharia Biológica e Química, Instituto Superior Técnico, Portugal

-Dr. Constantinos Pitris, Professor, Department of Electrical & Computer Engineering, University of Cyprus

-Dr. Geert Plaetinck, Head of RNAi Technology, Devgen, Belgium

-Prof. Dr. Igor Plazl, Associated Professor, Chemistry and Chemical Technology, University of Ljubljana, Slovenia

-Prof. Andreas Plückthun, Prof. Andreas Plückthun, Professor, Biochemistry Institute, Zurich University, Switzerland

-Dr. Aleš Podgornik, R&D Manager, BIA Separations d.o.o., Slovenia

-Prof. Dr. Jack Pronk, Scientific Director, Kluyver Centre for Genomics of Industrial Fermentation; Delft University of Technology, The Netherlands

-Dr. Antoni Rafalski, Senior Research Fellow, Pioneer Hi-Bred Intl. – a DuPont Compant, USA

-Prof. Arjen Rizjema, Wageningen University, Department of Food Technology and Nutritional Sciences, The Netherlands

-Dr. Joanna Rubinstein, Executive Director for Health & Science, United Nations Millennium Project and Senior Associate Dean, Global Initiatives; Columbia University, USA

-Dr. Patrick Rudelsheim, Chairman EFB Task Group Safety in Biotechnology, PERSEUS BVBA, Belgium

-Prof. Josep Samitier, Director, NanoBioengineering Laboratory, Institute for Bioengineering of Catalonia, University of Barcelona, Spain

-Dr. Lisbet Santoni, Narvalus s.r.l., Italy

-Prof. Uwe Sauer, Institute of Molecular Systems Biology, ETH Zurich, Switzerland

-Dr. Thomas Schäfer, Senior Director, New Business Development, Novozymes, Germany

-Dr. Raymond Schiffelers, Assistant Professor, Dept. Pharmaceutical Sciences, Utrecht University, The Netherlands

-Mr Harald Schmidt, Assistant Director, Nuffield Council on Bioethics, UK

-Dr. Ralf-Michael Schmidt, Vice President, BASF Plant Science, Germany

-Dr. Ismail Serageldin, Director, Bibliotheca Alexandrina, Egypt

-Prof. Luis Serrano, Barcelona Biomedical Research Park, Spain

-Prof. Roger Sheldon, Delft University of Technology / CLEA Technologies BV, The Netherlands

-Prof. Dr. Sakayu Shimizu, Professor, Division of Applied Life Sciences, Kyoto University, Japan

-Prof. Dr. Wim Soetaert, Laboratory for Industrial Microbiology and Biocatalysis, Faculty of Bioscience Engineering, Ghent University, Belgium

-Dr. Anker Sørensen, Manager Applied Research, Keygene N.V., The Netherlands

-Dr. Lucia de Souza, VP of ANBio (Brazilian Biosafety Association), Director of Cutting Edge Solutions GmbH (a Switzerland based consulting company) and a member of PRRI

-Prof. Friedrich Srienc, Biotechnology Institute, Department of Chemical Engineering and Materials Science, University of Minnesota, USA

-Dr. Mathieu Streefland, Scientist / PAT project leader, Netherlands Vaccine Institute, The Netherlands

-Mark Stitt, Research Group Leader, Max Planck Institute of Molecular Plant Physiology, Germany

-Dr. Michael Taussig, Head, Technology Research Group, The Babraham Institute, UK

-Prof. Bertrand Tavitian, Head, Laboratory for Experimental Molecular Imaging, CEA, France

-Mrs. Hanna Tegel, School of Biotechnology, Royal Institute of Technology (KTH), Sweden

-Dr. Sandy Thomas, Director of Foresight OSI, UK

-Dr. Eduardo Trigo, Director, CEO Group, Argentina

-Prof. Roman Tuma, Professor, Department of Biological and Environmenal Sciences, University of Helsinki, Finland

-Prof. Nicholas Turner, Professor of Chemical Biology & Director of the Centre of Excellence in Biocatalysis (CoEBio3), Manchester Interdisciplinary Biocentre, UK

-Dr. Mathias Uhlen, Professor of Microbiology, Royal Institute of Technology (KTH), Sweden

-Dr. Alfonso Valencia, Spanish Nacional Cancer Research Center

-Dr. Albert van den Berg, Group leader, BIOS/Lab-on-a-Chip group, University of Twente, MESA+ Institute for Nanotechnology, The Netherlands

-Dr. Piet van der Meer, Executive Secretary, PRRI, The Netherlands

-Dr. Menno Van der Waart, Group leader, BIOS/Lab-on-a-Chip group, University of Twente, MESA+ Institute for Nanotechnology, The Netherlands

-Dr. Jan Maarten van Dijl, Professor, Dept. of Pharmaceutical Biology, University of Groningen, The Netherlands

-Dr. Johan van Hylckama Vlieg, Principal Scientist, Fermentation and Flavour, NIZO food research, The Netherlands

-Dr. Michiel Van Lookeren Campagne, Head of Research – BioScience, Bayer CropScience, Belgium

-Em.Prof. Marc Van Montagu, EFB President; Scientific Advisor, Department of Plant Systems Biology, Ghent University, Belgium

-Dr. Antonio Villaverde, Professor of Microbiology, Autonomous University of Barcelona, Spain

-Dr. Andreas von Felde, Head energy crops, KWS SAAT AG, Germany

-Dr. Neil Weir, Senior VP, UCB Group, UK

-Dr. Roland Wohlgemuth, Chairman EFB Section on Applied Biocatalysis, Sigma-Aldrich, Switzerland

-Dr. Wenping Wu, Director, Microbial Discovery Unit, Novozymes, Denmark

-Prof. Dr. Ing. Dirk Weuster-Botz, Institute of Biochemical Engineering, Technical University of Munich, Germany

-Dr. Marcel Wubbolts, Director at the DSM Innovation Center, The Netherlands

-Dr. Huanming Yang, Director & Professor, Beijing Genomics Institute (BGI), China

-Prof. Marc Zabeau, Department of Plant Systems Biology, VIB/Gent University, Belgium

-Prof. Dani Zamir, Professor, Robert H. Smith Institute of Plant Sciences and Genetics in Agriculture, Hebrew University, Jerusalem